BioSpace News Archive

BioMidwest

Skyline Medical Announces Corporate Name Change to Precision Therapeutics

The new name has been chosen to better reflect the Company’s new strategic focus on applying artificial intelligence to precision medicine and drug discovery and marks a new chapter of the Company’s growth.

January 25, 2018
·
8 min read
Biotech Bay

Veracyte Announces 100,000th Afirma Test Performed to Reduce Unnecessary Surgeries in Thyroid Cancer Diagnosis

During National Thyroid Awareness Month in January, Veracyte, Inc. announced that to date it has performed 100,000 Afirma genomic tests to help reduce unnecessary surgeries in patients being evaluated for potential thyroid cancer.

January 25, 2018
·
5 min read
Drug Development

Zealand Pharma Hosts Capital Market Day: Accelerating the Late Stage Pipeline

Management will provide an update on the business and elaborate on why 2018 is set to be a transformational year for Zealand.

January 25, 2018
·
3 min read
Biotech Bay

Study Finds Z-CAN Program, Supported by Medicines360, Increased Use of LARCs by Women in Puerto Rico During Zika Outbreak

Medicines360, a global nonprofit women’s health pharmaceutical company with a mission of expanding access to quality medicines, today highlighted a new report published in The Lancet Public Health.

January 25, 2018
·
3 min read
Biotech Bay

Autonomic Technologies Release: First Prospective Registry in SPG Stimulation Demonstrates Pulsante Therapy Effectively Treats Painful, Disabling Cluster Headaches

Autonomic Technologies, today announced the publication of results from the Pathway R-1 Registry study demonstrating the Pulsante SPG Microstimulator System’s effectiveness in more than two-thirds of patients with cluster headache, a disabling neurological condition with no known cure.

January 25, 2018
·
4 min read
Business

PRA Health Sciences to Report Fourth Quarter 2017 Earnings

The Company will also host a conference call on Thursday, February 22, 2018 at 9:00 a.m. (ET) to discuss the results with members of the investment community.

January 25, 2018
·
1 min read
Business

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2017 Financial Results at 8 a.m. ET on February 8, 2018

February 8, 2018 at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET.

January 25, 2018
·
2 min read
Biotech Beach

Independent Study Reaffirms Penumbra Aspiration as Frontline Thrombectomy Approach for Acute Ischemic Stroke

The data showed that the ADAPT technique was non-inferior to stent retrievers for treatment of large vessel occlusions: 52 percent of patients treated with Penumbra’s aspiration system achieved the primary endpoint of modified Rankin Score (mRS) 0-2 at 90 days compared with 49 percent of patients treated with stent retrievers.

January 25, 2018
·
7 min read
OSE Immunotherapeutics Receives Notice of Allowance for New Patent by U.S. Patent and Trademark Office that Further Strengthens Intellectual Property Portfolio Around Tedopi in Immuno-Oncology Applications

The new patent extends the U.S. protection of Tedopi to several combinations of neoepitopes (peptides from various tumourous antigens optimized to bind strongly with HLA-A2 and T lymphocyte receptors) for use in cancer treatment.

January 25, 2018
·
6 min read
BioMidwest

Stryker’s Wingspan Stent Impresses in Post-Market Study

The new recommendation expanded the treatment window from six to 16 hours based on overwhelming clinical evidence.

January 25, 2018
·
3 min read